SHARIEF GROUP LIMITED

Sharief Group Limited operates a network of dispensing chemists, trading under the Allied Pharmacies brand.

About the company

Sharief Group Limited is a consumer staples company specializing in wholesale and retail trade, including the repair of motor vehicles. The group has shown significant financial growth, with a 34.4% increase in turnover and a 199.1% rise in profit before tax in the latest fiscal year. The company employs 193 people and operates under the FRS 102 accounting basis with an unqualified (clean) audit opinion.

• Successful launch and rapid expansion of the Pharmacy First scheme in January 2024.
• Significant financial pressures affecting the sector, including inflation, NIC, living wage, and skills shortages.
• Post-period-end sales of multiple pharmacies and subsidiaries, including Bell Walk Healthcare Limited, Buckburton Healthcare Limited, and K A Imrie Healthcare Limited.

Group structure

The group includes the following subsidiaries, among others:

• Allied Pharmacies Limited (100%)
• Sharief Healthcare Limited (100%)
• Oakfield Pharma Limited (60%)
• Blackthorn Healthcare Limited (60%)
• Core Pharmaceuticals Limited (100%)
• Middleway Pharmacy Limited (100%)

Leadership

Active directors:

• Suhaib Abdullah (Director, appointed 2020)
• Abdulsattar Sharief (Director, appointed 2023)
• Bilal Sharief (Director, appointed 2023)
• Musaab Sharief (Director, appointed 2023)
• Suhail Sharief (Director, appointed 2020)

Persons with significant control:

• Mr Suhail Sharief (75–100% shares, voting rights, and director appointments)